Distinct renal pathology and a chemotactic phenotype after enterohemorrhagic escherichia coli shiga toxins in non-human primate models of hemolytic uremic syndrome

American Journal of Pathology

Volumn 182, Issue 4, 2013, Pages 1227-1238

  Stearns Kurosawa, Deborah J ^a   Oh, Sun Young ^a   Cherla, Rama P ^b   Lee, Moo Seung ^b   Tesh, Vernon L ^b   Papin, James ^a   Henderson, Joel ^a   Kurosawa, Shinichiro ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; VEROTOXIN 1; VEROTOXIN 2;

ARTICLE; BABOON; DISEASE SEVERITY; ELECTRON MICROSCOPY; ENTEROHEMORRHAGIC ESCHERICHIA COLI; HEMOLYTIC UREMIC SYNDROME; KIDNEY; KIDNEY INJURY; KIDNEY TUBULE DAMAGE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN URINE LEVEL; SHIGA TOXIN PRODUCING ESCHERICHIA COLI;

ANIMALS; CHEMOKINES; CHEMOTAXIS; DISEASE MODELS, ANIMAL; ENDOTHELIAL CELLS; ENTEROHEMORRHAGIC ESCHERICHIA COLI; EOSINOPHILS; GENE EXPRESSION REGULATION; HEMOLYTIC-UREMIC SYNDROME; HUMANS; INFLAMMATION; KIDNEY; MESANGIAL CELLS; PAPIO; PHENOTYPE; RNA, MESSENGER; SHIGA TOXIN 1; SHIGA TOXIN 2; SHIGA TOXINS;

EID: 84875184084     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2012.12.026     Document Type: Article

References (57)

1. A. Gerber, H. Karch, F. Allerberger, H.M. Verweyen, and L.B. Zimmerhackl Clinical course and the role of shiga toxin-producing Escherichia coli infection in the hemolytic-uremic syndrome in pediatric patients, 1997-2000, in Germany and Austria: a prospective study J Infect Dis 186 2002 493 500
2. H.R. Smith, B. Rowe, R.J. Gross, N.K. Fry, and S.M. Scotland Haemorrhagic colitis and Vero-cytotoxin-producing Escherichia coli in England and Wales Lancet 1 1987 1062 1065
3. M.I. Mota, M.P. Gadea, S. Gonzalez, G. Gonzalez, L. Pardo, A. Sirok, M. Rivas, G. Algorta, F. Schelotto, and G. Varela Bacterial pathogens associated with bloody diarrhea in Uruguayan children Rev Argent Microbiol 42 2010 114 117
4. P.S. Mead, L. Slutsker, V. Dietz, L.F. McCaig, J.S. Bresee, C. Shapiro, P.M. Griffin, and R.V. Tauxe Food-related illness and death in the United States Emerg Infect Dis 5 1999 607 625
5. A. Garcia, C.J. Bosques, J.S. Wishnok, Y. Feng, B.J. Karalius, J.R. Butterton, D.B. Schauer, A.B. Rogers, and J.G. Fox Renal injury is a consistent finding in Dutch Belted rabbits experimentally infected with enterohemorrhagic Escherichia coli J Infect Dis 193 2006 1125 1134
6. H. Karch, P.I. Tarr, and M. Bielaszewska Enterohaemorrhagic Escherichia coli in human medicine Int J Med Microbiol 295 2005 405 418
7. P.I. Tarr, C.A. Gordon, and W.L. Chandler Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome Lancet 365 2005 1073 1086
8. L.H. Gould, L. Demma, T.F. Jones, S. Hurd, D.J. Vugia, K. Smith, B. Shiferaw, S. Segler, A. Palmer, S. Zansky, and P.M. Griffin Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection. foodborne diseases active surveillance network sites, 2000-2006 Clin Infect Dis 49 2009 1480 1485
9. M.J. Brady, P. Radhakrishnan, H. Liu, L. Magoun, K.C. Murphy, J. Mukherjee, A. Donohue-Rolfe, S. Tzipori, and J.M. Leong Enhanced actin pedestal formation by enterohemorrhagic Escherichia coli O157:H7 adapted to the mammalian host Front Microbiol 2 2011 226
10. P. Boerlin, S.A. McEwen, F. Boerlin-Petzold, J.B. Wilson, R.P. Johnson, and C.L. Gyles Associations between virulence factors of shiga toxin-producing Escherichia coli and disease in humans J Clin Microbiol 37 1999 497 503
11. H. Chart, and T. Cheasty Human infections with verocytotoxin-producing Escherichia coli O157-10 years of E. coli O157 serodiagnosis J Med Microbiol 57 2008 1389 1393
12. M. Bielaszewska, A. Mellmann, W. Zhang, R. Köck, A. Fruth, A. Bauwens, G. Peters, and H. Karch Characterisation of the Escherichia coli strain associated with an outbreak of haemolytic uraemic syndrome in Germany, 2011: a microbiological study Lancet Infect Dis 11 2011 671 676
13. T. Magnus, J. Rother, O. Simova, M. Meier-Cillien, J. Repenthin, F. Moller, J. Gbadamosi, U. Panzer, M. Wengenroth, C. Hagel, S. Kluge, R.K. Stahl, K. Wegscheider, P. Urban, B. Eckert, M. Glatzel, J. Fiehler, and C. Gerloff The neurological syndrome in adults during the 2011 northern German E. coli serotype O104:H4 outbreak Brain 135 2012 1850 1859
14. C. Frank, M. Faber, M. Askar, H. Bernard, A. Fruth, A. Gilsdorf, M. Hohle, H. Karch, G. Krause, R. Prager, A. Spode, K. Stark, and D. Werber Large and ongoing outbreak of haemolytic uraemic syndrome. Germany, May 2011 Euro Surveill 16 2011 1 3
15. C.S. Wong, J.C. Mooney, J.R. Brandt, A.O. Staples, S. Jelacic, D.R. Boster, S.L. Watkins, and P.I. Tarr Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis Clin Infect Dis 55 2012 33 41
16. K.I. Jeong, S. Tzipori, and A.S. Sheoran Shiga toxin 2-specific but not shiga toxin 1-specific human monoclonal antibody protects piglets challenged with enterohemorrhagic Escherichia coli producing shiga toxin 1 and shiga toxin 2 J Infect Dis 201 2010 1081 1083
17. D.J. Stearns-Kurosawa, V. Collins, S. Freeman, V.L. Tesh, and S. Kurosawa Distinct physiologic and inflammatory responses elicited in baboons after challenge with Shiga toxin type 1 or 2 from enterohemorrhagic Escherichia coli Infect Immun 78 2010 2497 2504
18. D.J. Stearns-Kurosawa, V. Collins, S. Freeman, D. Debord, K. Nishikawa, S.Y. Oh, C.S. Leibowitz, and S. Kurosawa Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide Pediatr Nephrol 26 2011 2031 2039
19. D.J. Stearns-Kurosawa, F. Lupu, F.B. Taylor Jr., G. Kinasewitz, and S. Kurosawa Sepsis and pathophysiology of anthrax in a nonhuman primate model Am J Pathol 169 2006 433 444
20. F.B. Taylor Jr., V.L. Tesh, L. DeBault, A. Li, A.C. Chang, S.D. Kosanke, T.J. Pysher, and R.L. Siegler Characterization of the baboon responses to Shiga-like toxin: descriptive study of a new primate model of toxic responses to Stx-1 Am J Pathol 154 1999 1285 1299
21. C.D. Inward, A.J. Howie, M.M. Fitzpatrick, F. Rafaat, D.V. Milford, and C.M. Taylor Renal histopathology in fatal cases of diarrhoea-associated haemolytic uraemic syndrome. British Association for Paediatric Nephrology Pediatr Nephrol 11 1997 556 559
22. U. Chaisri, M. Nagata, H. Kurazono, H. Horie, P. Tongtawe, H. Hayashi, T. Watanabe, P. Tapchaisri, M. Chongsa-nguan, and W. Chaicumpa Localization of Shiga toxins of enterohaemorrhagic Escherichia coli in kidneys of paediatric and geriatric patients with fatal haemolytic uraemic syndrome Microb Pathog 31 2001 59 67
23. T. Nakagawa, K. Tanabe, B.P. Croker, R.J. Johnson, M.B. Grant, T. Kosugi, and Q. Li Endothelial dysfunction as a potential contributor in diabetic nephropathy Nat Rev Nephrol 7 2011 36 44
24. A. Sinha, G. Singh, A. Bhat, S. Mohapatra, A. Gulati, P. Hari, J. Samantaray, A. Dinda, S. Agarwal, and A. Bagga Thrombotic microangiopathy and acute kidney injury following vivax malaria Clin Exp Nephrol 2012 1 7
25. C.J. Diskin, T.J. Stokes, L.M. Dansby, L. Radcliff, and T.B. Carter The prevalence and meaning of eosinophilia in renal diseases on a nephrology consultation service Nephrol Dial Transplant 26 2011 2549 2558
26. A. Panda, I. Tatarov, A.R. Melton-Celsa, K. Kolappaswamy, E.H. Kriel, D. Petkov, T. Coksaygan, S. Livio, C.G. McLeod, J.P. Nataro, A.D. O'Brien, and L.J. DeTolla Escherichia coli O157:H7 infection in Dutch belted and New Zealand white rabbits Comp Med 60 2010 31 37
27. T. Tsukahara, N. Nakanishi, K. Nakayama, N. Matsubara, and K. Ushida Experimental infection of enterotoxemic Escherichia coli associated with porcine edema disease and its pathologic characteristics in the intestine J Vet Med Sci 67 2005 1167 1171
28. R.A. de Lind van Wijngaarden, H.A. Hauer, R. Wolterbeek, D.R. Jayne, G. Gaskin, N. Rasmussen, L.H. Noel, F. Ferrario, R. Waldherr, E.C. Hagen, J.A. Bruijn, and I.M. Bajema Clinical and histologic determinants of renal outcome in ANCA-associated vasculitis: a prospective analysis of 100 patients with severe renal involvement J Am Soc Nephrol 17 2006 2264 2274
29. R.F. Wolf, R. Eberle, and G.L. White Generation of a specific-pathogen- free baboon colony J Am Assoc Lab Anim Sci 49 2010 814 820
30. F.B. Taylor Jr., D.J. Stearns-Kurosawa, S. Kurosawa, G. Ferrell, A.C. Chang, Z. Laszik, S. Kosanke, G. Peer, and C.T. Esmon The endothelial cell protein C receptor aids in host defense against Escherichia coli sepsis Blood 95 2000 1680 1686
31. C. Moosbauer, E. Morgenstern, S.L. Cuvelier, D. Manukyan, K. Bidzhekov, S. Albrecht, P. Lohse, K.D. Patel, and B. Engelmann Eosinophils are a major intravascular location for tissue factor storage and exposure Blood 109 2007 995 1002
32. M.A. Sovershaev, K.F. Lind, H. Devold, T.Ø. Jørgensen, J.B. Hansen, B. Østerud, and E.M. Egorina No evidence for the presence of tissue factor in high-purity preparations of immunologically isolated eosinophils J Thromb Haemost 6 2008 1742 1749
33. G.J. Gleich Mechanisms of eosinophil-associated inflammation J Allergy Clin Immunol 105 2000 651 663
34. M. Brigotti, P.L. Tazzari, E. Ravanelli, D. Carnicelli, L. Rocchi, V. Arfilli, G. Scavia, F. Minelli, F. Ricci, P. Pagliaro, A.V. Ferretti, C. Pecoraro, F. Paglialonga, A. Edefonti, M.A. Procaccino, A.E. Tozzi, and A. Caprioli Clinical relevance of shiga toxin concentrations in the blood of patients with hemolytic uremic syndrome Pediatr Infect Dis J 30 2011 486 490
35. M. Brigotti, P.L. Tazzari, E. Ravanelli, D. Carnicelli, S. Barbieri, L. Rocchi, V. Arfilli, G. Scavia, F. Ricci, A. Bontadini, R.R. Alfieri, P.G. Petronini, C. Pecoraro, A.E. Tozzi, and A. Caprioli Endothelial damage induced by Shiga toxins delivered by neutrophils during transmigration J Leukoc Biol 88 2010 201 210
36. D.M. te Loo, L.A. Monnens, T.J. van Der Velden, M.A. Vermeer, F. Preyers, P.N. Demacker, L.P. van Den Heuvel, and V.W. van Hinsbergh Binding and transfer of verocytotoxin by polymorphonuclear leukocytes in hemolytic uremic syndrome Blood 95 2000 3396 3402
37. T.N. Petruzziello-Pellegrini, D.A. Yuen, A.V. Page, S. Patel, A.M. Soltyk, C.C. Matouk, D.K. Wong, P.J. Turgeon, J.E. Fish, J.J. Ho, B.M. Steer, V. Khajoee, J. Tigdi, W.L. Lee, D.G. Motto, A. Advani, R.E. Gilbert, S.A. Karumanchi, L.A. Robinson, P.I. Tarr, W.C. Liles, J.L. Brunton, and P.A. Marsden The CXCR4/CXCR7/SDF-1 pathway contributes to the pathogenesis of Shiga toxin-associated hemolytic uremic syndrome in humans and mice J Clin Invest 122 2012 759 776
38. F. Guessous, M. Marcinkiewicz, R. Polanowska-Grabowska, S. Kongkhum, D. Heatherly, T. Obrig, and A.R.L. Gear Shiga toxin 2 and lipopolysaccharide induce human microvascular endothelial cells to release chemokines and factors that stimulate platelet function Infect Immun 73 2005 8306 8316
39. A.W. Friedrich, M. Bielaszewska, W.L. Zhang, M. Pulz, T. Kuczius, A. Ammon, and H. Karch Escherichia coli harboring Shiga toxin 2 gene variants: frequency and association with clinical symptoms J Infect Dis 185 2002 74 84
40. T. Okuda, N. Tokuda, Numata Si, M. Ito, M. Ohta, K. Kawamura, J. Wiels, T. Urano, O. Tajima, K. Furukawa, and K. Furukawa Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins J Biol Chem 281 2006 10230 10235
41. H. Nakajima, N. Kiyokawa, Y.U. Katagiri, T. Taguchi, T. Suzuki, T. Sekino, K. Mimori, T. Ebata, M. Saito, H. Nakao, T. Takeda, and J. Fujimoto Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance J Biol Chem 276 2001 42915 42922
42. M.D. Cummings, H. Ling, G.D. Armstrong, J.L. Brunton, and R.J. Read Modeling the carbohydrate-binding specificity of pig edema toxin Biochemistry 37 1998 1789 1799
43. A. Kiarash, B. Boyd, and C.A. Lingwood Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues J Biol Chem 269 1994 11138 11146
44. S. Arab, and C.A. Lingwood Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to verotoxin via globotriaosyl ceramide fatty acid isoform traffic J Cell Physiol 177 1998 646 660
45. T.G. Obrig, C.B. Louise, C.A. Lingwood, B. Boyd, L. Barley-Maloney, and T.O. Daniel Endothelial heterogeneity in Shiga toxin receptors and responses J Biol Chem 268 1993 15484 15488
46. M. Warnier, W. Romer, J. Geelen, J. Lesieur, M. Amessou, L. van den Heuvel, L. Monnens, and L. Johannes Trafficking of Shiga toxin/Shiga-like toxin-1 in human glomerular microvascular endothelial cells and human mesangial cells Kidney Int 70 2006 2085 2092
47. F. Clayton, T.J. Pysher, R. Lou, D.E. Kohan, N.D. Denkers, V.L. Tesh, F.B. Taylor Jr., and R.L. Siegler Lipopolysaccharide upregulates renal shiga toxin receptors in a primate model of hemolytic uremic syndrome Am J Nephrol 25 2005 536 540
48. J. Muthing, C.H. Schweppe, H. Karch, and A.W. Friedrich Shiga toxins, glycosphingolipid diversity, and endothelial cell injury Thromb Haemost 101 2009 252 264
49. T. Falguieres, W. Romer, M. Amessou, C. Afonso, C. Wolf, J.C. Tabet, C. Lamaze, and L. Johannes Functionally different pools of Shiga toxin receptor, globotriaosyl ceramide, in HeLa cells FEBS J 273 2006 5205 5218
50. E.K. Lentz, R.P. Cherla, V. Jaspers, B.R. Weeks, and V.L. Tesh Role of tumor necrosis factor alpha in disease using a mouse model of Shiga toxin-mediated renal damage Infect Immun 78 2010 3689 3699
51. T.R. Keepers, M.A. Psotka, L.K. Gross, and T.G. Obrig A murine model of HUS: shiga toxin with lipopolysaccharide mimics the renal damage and physiologic response of human disease J Am Soc Nephrol 17 2006 3404 3414
52. K.L. Mohawk, and A.D. O'Brien Mouse models of Escherichia coli O157:H7 infection and shiga toxin injection J Biomed Biotechnol 2011 2011 258185
53. F.B. Taylor, C.H. Toh, W.K. Hoots, H. Wada, and M. Levi Scientific Subcommittee on Disseminated Intravascular Coagulation (DIC) of the International Society on Thrombosis and Haemostasis (ISTH): Towards definition, clinical and laboratory criteria, and a scoring system for disseminated intravascular coagulation Thromb Haemost 86 2001 1327 1330
54. D.J. Stearns-Kurosawa, M.F. Osuchowski, C. Valentine, S. Kurosawa, and D.G. Remick The pathogenesis of sepsis Annu Rev Pathol 6 2011 19 48
55. S.B. Haudek, B.E. Natmessnig, W. Furst, S. Bahrami, G. Schlag, and H. Redl Lipopolysaccharide dose response in baboons Shock 20 2003 431 436
56. D.J. Stearns-Kurosawa, V. Collins, S. Freeman, D. Debord, K. Nishikawa, S.-Y. Oh, C.S. Leibowitz, and S. Kurosawa Rescue from lethal Shiga toxin 2-induced renal failure with a cell-permeable peptide Pediatr Nephrol 26 2011 2031 2039
57. R.S. Oakes, J.K. Kirkham, R.D. Nelson, and R.L. Siegler Duration of oliguria and anuria as predictors of chronic renal-related sequelae in post-diarrheal hemolytic uremic syndrome Pediatr Nephrol 23 2008 1303 1308